Search Results for

“߱ġóƮ âš ã65. <<========= ǰ ͳ ߱ġ ǰڹ ó ̾౸ űȯ Ź ̵巹ó”

Sandoz receives Health Canada approval for Jubbonti^®, first and only denosumab biosimilar for treatment of osteoporosis.

May 31, 2024

Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]

View >

Early Screening Tool for Osteoporosis To Receive Funding

January 23, 2023

On January 18, 2023, INOVAIT and the Government of Canada announced a major investment in the field of image-guided therapy (IGT).

View >